This study confirms that D-2-HG suppresses glioma growth in a variety of model systems and demonstrates that a contributing mechanism involves D-2-HG–mediated inhibition of the RNA m6A demethylase FTO. This evidence concerns the gene FTO and central nervous system cancer.